Decreased expression of response gene to complement 32 in psoriasis and its association with reduced M2 macrophage polarization
暂无分享,去创建一个
Sungwon Jung | Eun-Hui Lee | J. Roh | YunJae Jung | H. Kim | Jinsun Jang
[1] Shinichi Sato,et al. CX3CR1 deficiency attenuates imiquimod-induced psoriasis-like skin inflammation with decreased M1 macrophages. , 2016, Journal of dermatological science.
[2] P. Li,et al. Response gene to complement 32 (RGC-32) expression on M2-polarized and tumor-associated macrophages is M-CSF-dependent and enhanced by tumor-derived IL-4 , 2014, Cellular and Molecular Immunology.
[3] M. Roussel,et al. TNF Counterbalances the Emergence of M2 Tumor Macrophages. , 2015, Cell reports.
[4] Kristina M. Little,et al. IL-17A Influences Essential Functions of the Monocyte/Macrophage Lineage and Is Involved in Advanced Murine and Human Atherosclerosis , 2014, The Journal of Immunology.
[5] Shi-You Chen,et al. Response Gene to Complement 32 Protein Promotes Macrophage Phagocytosis via Activation of Protein Kinase C Pathway* , 2014, The Journal of Biological Chemistry.
[6] C. Bever,et al. Dual role of Response gene to complement-32 in multiple sclerosis. , 2013, Experimental and molecular pathology.
[7] Lisa C. Zaba,et al. A subpopulation of CD163-positive macrophages is classically activated in psoriasis. , 2010, The Journal of investigative dermatology.